GB0613567D0 - Crystalline sodium atorvastatin - Google Patents

Crystalline sodium atorvastatin

Info

Publication number
GB0613567D0
GB0613567D0 GB0613567A GB0613567A GB0613567D0 GB 0613567 D0 GB0613567 D0 GB 0613567D0 GB 0613567 A GB0613567 A GB 0613567A GB 0613567 A GB0613567 A GB 0613567A GB 0613567 D0 GB0613567 D0 GB 0613567D0
Authority
GB
United Kingdom
Prior art keywords
crystalline sodium
sodium atorvastatin
atorvastatin
crystalline
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0613567A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chongqing Shenghuaxi Pharmaceutical Co Ltd
Arrow International Ltd
Original Assignee
Chongqing Shenghuaxi Pharmaceutical Co Ltd
Arrow International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chongqing Shenghuaxi Pharmaceutical Co Ltd, Arrow International Ltd filed Critical Chongqing Shenghuaxi Pharmaceutical Co Ltd
Priority to GB0613567A priority Critical patent/GB0613567D0/en
Priority to AU2006281237A priority patent/AU2006281237A1/en
Priority to NZ566287A priority patent/NZ566287A/en
Priority to CN200680034164XA priority patent/CN101268047B/en
Priority to EP06765284.2A priority patent/EP1924555B1/en
Priority to PCT/GB2006/003035 priority patent/WO2007020421A1/en
Priority to BRPI0614280-0A priority patent/BRPI0614280A2/en
Priority to CA2619040A priority patent/CA2619040C/en
Priority to JP2008526540A priority patent/JP2009542579A/en
Priority to US11/504,103 priority patent/US8017647B2/en
Publication of GB0613567D0 publication Critical patent/GB0613567D0/en
Priority to US13/112,377 priority patent/US8440712B2/en
Ceased legal-status Critical Current

Links

GB0613567A 2005-08-15 2006-07-07 Crystalline sodium atorvastatin Ceased GB0613567D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GB0613567A GB0613567D0 (en) 2006-07-07 2006-07-07 Crystalline sodium atorvastatin
PCT/GB2006/003035 WO2007020421A1 (en) 2005-08-15 2006-08-14 Crystalline and amorphous sodium atorvastatin
NZ566287A NZ566287A (en) 2005-08-15 2006-08-14 Crystalline and amorphous sodium atorvastatin
CN200680034164XA CN101268047B (en) 2005-08-15 2006-08-14 Crystalline and amorphous sodium atorvastatin
EP06765284.2A EP1924555B1 (en) 2005-08-15 2006-08-14 Process for the preparation of crystalline sodium atorvastatin
AU2006281237A AU2006281237A1 (en) 2005-08-15 2006-08-14 Crystalline and amorphous sodium atorvastatin
BRPI0614280-0A BRPI0614280A2 (en) 2005-08-15 2006-08-14 crystalline and amorphous sodium atorvastatin
CA2619040A CA2619040C (en) 2005-08-15 2006-08-14 Crystalline and amorphous sodium atorvastatin
JP2008526540A JP2009542579A (en) 2006-07-07 2006-08-14 Crystalline and amorphous atorvastatin sodium
US11/504,103 US8017647B2 (en) 2005-08-15 2006-08-15 Crystalline sodium atorvastatin
US13/112,377 US8440712B2 (en) 2005-08-15 2011-05-20 Crystalline sodium atorvastatin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0613567A GB0613567D0 (en) 2006-07-07 2006-07-07 Crystalline sodium atorvastatin

Publications (1)

Publication Number Publication Date
GB0613567D0 true GB0613567D0 (en) 2006-08-16

Family

ID=36926666

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0613567A Ceased GB0613567D0 (en) 2005-08-15 2006-07-07 Crystalline sodium atorvastatin

Country Status (2)

Country Link
JP (1) JP2009542579A (en)
GB (1) GB0613567D0 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4681893A (en) * 1986-05-30 1987-07-21 Warner-Lambert Company Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
PT1727795E (en) * 2004-03-17 2012-04-11 Ranbaxy Lab Ltd Process for the production of atorvastatin calcium in amorphous form
WO2005090301A1 (en) * 2004-03-17 2005-09-29 Ranbaxy Laboratories Limited Crystalline form of atorvastatin hemi calcium
US7875731B2 (en) * 2004-05-05 2011-01-25 Pfizer Inc. Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)Carbonyl]-1H-pyrrole-1-heptanoic acid
WO2006032959A2 (en) * 2004-08-06 2006-03-30 Glenmark Pharmaceuticals Limited Processes for the preparation of pyrrole derivatives
JP2008510798A (en) * 2004-08-27 2008-04-10 バイオコン・リミテッド Method for amorphous atorvastatin calcium
CN100503564C (en) * 2005-08-15 2009-06-24 浙江新东港药业股份有限公司 Process for preparing high purity crystal atorvastatin sodium

Also Published As

Publication number Publication date
JP2009542579A (en) 2009-12-03

Similar Documents

Publication Publication Date Title
HUS1900033I1 (en) Substituted enaminocarbonyl compounds
ZA200808639B (en) Oxadiazolidinedione compound
GB0602424D0 (en) Compounds
GB0602046D0 (en) Compounds
EP1985620A4 (en) 10a-AZALIDE COMPOUND
EP1984379A4 (en) Anti-arenaviral compounds
EP2000469A4 (en) Acylaminopiperidine compound
ZA200903614B (en) New crystalline forms
GB0607096D0 (en) Compound
EP2082022A4 (en) Compounds
IL188219A0 (en) Crystalline form rabeprazole sodium
IL195061A0 (en) Crystalline forms of atorvastatin
EP2004174A4 (en) Naphthalenedione compounds
GB0604142D0 (en) Compound
GB0602042D0 (en) Compounds
ZA200806859B (en) Novel crystalline compounds
EP1973905A4 (en) Compounds
GB0613566D0 (en) Crystalline sodium atorvastatin
ZA200901570B (en) Substituted azolin-2-YL-amino compounds
EP2016069A4 (en) Bis-pyridinium compounds
GB0602560D0 (en) Compounds
GB0602412D0 (en) Compounds
GB0600427D0 (en) Compounds
GB0613567D0 (en) Crystalline sodium atorvastatin
HU0600120D0 (en) New crystalline atorvastatin hemicalcium

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)